| Literature DB >> 21810205 |
Dmitry A Rodionov1, Pavel S Novichkov, Elena D Stavrovskaya, Irina A Rodionova, Xiaoqing Li, Marat D Kazanov, Dmitry A Ravcheev, Anna V Gerasimova, Alexey E Kazakov, Galina Yu Kovaleva, Elizabeth A Permina, Olga N Laikova, Ross Overbeek, Margaret F Romine, James K Fredrickson, Adam P Arkin, Inna Dubchak, Andrei L Osterman, Mikhail S Gelfand.
Abstract
BACKGROUND: Genome-scale prediction of gene regulation and reconstruction of transcriptional regulatory networks in bacteria is one of the critical tasks of modern genomics. The Shewanella genus is comprised of metabolically versatile gamma-proteobacteria, whose lifestyles and natural environments are substantially different from Escherichia coli and other model bacterial species. The comparative genomics approaches and computational identification of regulatory sites are useful for the in silico reconstruction of transcriptional regulatory networks in bacteria.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21810205 PMCID: PMC3223726 DOI: 10.1186/1471-2164-12-S1-S3
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Phylogenetic tree, isolation site characteristics and the geographic origin of 20 Shewanella species with available genomes. The tree was constructed using the concatenated alignment of ~78 universal prokaryotic proteins in the MicrobesOnline database http://www.microbesonline.org/cgi-bin/speciesTree.cgi.
Figure 2Distribution by protein families of predicted DNA-binding transcription factors in the Shewanella genomes.
Previously known TF regulons reconstructed in Shewanella spp.
| TF name | Regulon functional role | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AgaR | - | - | - | + | + | + | - | - | - | + | - | - | - | - | - | - | - | rs | GalNAc utilization |
| ArgR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Arginine biosynthesis |
| BetI | - | - | - | - | - | - | + | + | + | - | - | + | + | + | + | + | + | rs | Osmotic protection |
| BirA | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Biotin biosynthesis |
| Crp | r | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Global regulon |
| CueR | + | + | + | + | + | + | + | + | - | + | - | + | + | + | + | + | rs | rs | Copper efflux |
| Dnr | - | - | - | - | - | - | - | + | - | + | + | - | - | - | - | - | rs | - | Denitrification |
| FabR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Fatty acid biosynthesis |
| FadR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Fatty acid degradation |
| Fnr | r | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Global regulon |
| Fur | rs | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | rs | Iron homeostasis |
| GalR | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | rs | Galactose utilization |
| GcvA | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Glycine metabolism |
| GlmR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | r | - | LPS synthesis |
| GntR | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | + | rs | Gluconate utilization |
| HexR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | + | Central sugar metabolism |
| HutC | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | r | - | Histidine utilization |
| IlvY | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Isoleucine-valine synthesis |
| IscR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Fe-S cluster assembly |
| LexA | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | rs | DNA damage stress |
| MetJ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Methionine biosynthesis |
| MetR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Methionine biosynthesis |
| ModE | + | - | - | + | + | + | + | - | - | - | - | - | - | - | - | - | + | rs | Molybdenium metabolism |
| NanR | - | - | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | rs | Sialic acid utilization |
| NarP | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | + | - | rs | Nitrate/nitrite respiration |
| NhaR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Osmotic stress protection |
| NikR | - | - | - | - | - | - | - | - | - | - | - | + | + | - | + | - | + | rs | Nickel uptake |
| NorR | - | + | + | + | + | + | - | - | + | + | + | + | + | + | + | + | + | rs | Nitrosative stress |
| NrdR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | Nucleotide metabolism |
| NrtR | rs | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | Nicotinamide utilization |
| NsrR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Nitrosative stress |
| NtrC | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | rs | Nitrogen assimilation |
| PdhR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Pyruvate metabolism |
| PsrA | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs | - | Fatty acid degradation |
| RbsR | - | - | - | - | - | - | - | - | - | - | - | + | + | - | - | - | + | rs | Ribose utilization |
| SdaR | + | + | + | + | + | + | + | - | + | - | + | + | + | + | + | + | + | r | Glycerate utilization |
| SoxR | - | - | - | - | - | - | - | + | + | + | + | - | - | - | - | + | + | rs | Superoxide stress |
| TorR | rs | - | - | + | + | + | + | - | + | + | + | + | + | + | + | + | - | rs | TMAO respiration |
| TrpR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Amino acid metabolism |
| TyrR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | rs* | rs | Amino acid metabolism |
| ZntR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | - | rs | Zinc efflux |
The presence of orthologous transcription factors is shown by '+', 'r' and 'rs', whereas its absence is denoted by '-'. TFs with previously characterized target genes in model species are denoted by 'r'. TFs with previously known TFBSs at their target genes are denoted by 'rs'. Ortholog of TyrR in Pseudomonas spp. that was characterized as the phenylalanine and tyrosine catabolism regulator PhhR is marked by asterisk.
Novel TF regulons predicted and reconstructed in Shewanella spp.
| TF name | Regulon functional role | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AlgR* | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | Hexuronate utilization |
| AraR* | - | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - | Arabinose utilization |
| BglR* | - | - | - | - | - | - | + | + | + | + | - | - | - | + | - | + | Beta-glucoside utilization |
| HmgR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Tyrosine degradation |
| HypR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Hydroxyproline utilization |
| LiuR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Amino acid utilization |
| LldR* | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | - | Lactate utilization |
| MalR* | + | - | - | + | + | + | + | + | + | + | + | - | - | + | - | + | Maltodextrin utilization |
| ManR1* | - | - | - | - | - | + | - | - | - | + | - | - | - | - | - | - | Mannose utilization |
| ManR2* | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | Mannose utilization |
| MtlR2 | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | Mannitol utilization |
| NagR | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | GlcNAc utilization |
| PflR* | - | + | + | - | - | - | - | - | + | + | + | + | + | + | + | + | Formate metabolism |
| PrpR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Propionate utilization |
| PUR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Purine biosynthesis |
| ScrR* | - | - | - | + | + | + | + | - | + | - | - | - | - | - | - | - | Sucrose utilization |
| TreR* | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | + | Trehalose utilization |
| XltR* | - | - | - | - | - | - | - | - | - | - | - | + | + | - | - | - | Xylitol utilization |
| AzrR* | + | + | + | + | + | + | + | - | - | + | + | + | + | + | + | + | Superoxide stress |
| CalR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Aromatics utilization |
| CueR2 | - | + | - | - | - | - | - | - | + | - | + | - | - | - | - | - | Copper efflux |
| DeoR* | + | + | + | + | - | - | - | - | - | - | - | + | + | + | + | + | Nucleoside utilization |
| PnuR* | + | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | NAD metabolism |
| SO0072 | + | + | + | + | + | + | + | + | + | + | + | + | - | + | - | + | ABC efflux transporter |
| SO0082 | + | - | - | - | + | - | + | - | + | - | - | - | - | - | - | - | Benzoate degradation |
| SO0193 | + | + | + | + | + | + | + | - | + | + | + | - | - | - | - | - | Phospholipid synthesis |
| SO0734 | + | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | hypothetical transporter |
| SO1393 | + | - | - | + | + | + | - | - | - | - | + | - | - | - | - | - | hypothetical |
| SO1415 | + | - | - | - | + | - | - | - | - | - | + | + | + | - | + | - | flavocytochrome c |
| SO1578 | + | - | - | + | + | + | + | - | - | + | + | - | - | - | - | + | Glutathione detoxification |
| SO1703 | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | - | multidrug efflux |
| SO1758 | + | + | + | + | + | + | + | - | - | + | + | - | - | - | + | + | hypothetical |
| SO2282 | + | + | + | + | + | + | + | - | - | + | - | + | + | + | - | + | Amino acid efflux |
| SO3277 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | multidrug efflux |
| SO3385 | + | + | + | + | + | + | + | - | - | - | - | - | - | - | - | - | hypothetical |
| SO3393 | + | + | + | + | + | + | + | + | + | + | + | - | - | + | + | + | xenobiotic reductase |
| SO3494 | + | + | + | + | + | + | + | + | + | - | - | - | - | - | - | - | multidrug efflux |
| SO3627 | + | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | flavocytochrome c |
| SO4326 | + | - | - | + | - | - | - | - | - | + | - | + | + | + | + | + | multidrug efflux |
| SO4468 | + | + | + | + | + | + | + | + | - | + | - | - | - | + | + | - | hypothetical |
| SO4705 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | hypothetical |
The new TF names introduced in this work are marked by asterisks.
Figure 3Metabolic context of the reconstructed regulons in Shewanella spp.
Figure 4Multiple regulation of branched chain amino acid utilization regulon LiuR in Shewanella oneidensis MR-1